GlobeStar Therapeutics Corporation
GSTC
$0.00
$0.000.00%
OTC PK
| 06/30/2024 | 03/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 15.39% | 7.50% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 15.39% | 7.50% | |||
| Operating Income | -15.39% | -7.50% | |||
| Income Before Tax | -12.97% | -6.84% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.97% | -6.84% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.97% | -6.84% | |||
| EBIT | -15.39% | -7.50% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | 0.00% | |||
| Normalized Basic EPS | 0.00% | 0.00% | |||
| EPS Diluted | 0.00% | 0.00% | |||
| Normalized Diluted EPS | 0.00% | 0.00% | |||
| Average Basic Shares Outstanding | 7.27% | 12.26% | |||
| Average Diluted Shares Outstanding | 7.27% | 12.26% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||